Chemistry: analytical and immunological testing – Involving immune complex formed in liquid phase – Separation of immune complex from unbound antigen or antibody
Patent
1982-07-21
1985-12-17
Nucker, Christine M.
Chemistry: analytical and immunological testing
Involving immune complex formed in liquid phase
Separation of immune complex from unbound antigen or antibody
260112R, 2601125R, 436543, 436545, 436811, 436813, 436815, 436547, G01N 3354, G01N 3358, A61K 3900, C07C10352
Patent
active
045593116
ABSTRACT:
Method for the diagnosis of cancer tumors which comprises determining the concentration of oncofetal urine peptide in the blood serum or the urine of the patient. The oncofetal urine peptide is immunochemically identifiable by means of an antiserum which is produced by the immunization of purified oncofetal urine peptide. The purification method has the following steps:
REFERENCES:
patent: 3663684 (1972-05-01), Freedman
patent: 4140753 (1979-02-01), Edgington et al.
patent: 4331647 (1982-05-01), Goldenberg
patent: 4361544 (1982-11-01), Goldenberg
Rees et al., J. Nat'l Cancer Inst., 67 (1981) 557-61.
Irie et al., Cancer Res., 36 (1976) 3510-17.
Fritsche et al., Nature, vol. 258 (Dec. 1975) 734-737.
Goldenberg et al., Cancer Res., 38 (1978) 1246-1249.
Irie et al., J. Nat. Cancer Inst., 63 (1979) 367-373.
Cauchi et al., Chem. Abstracts, 96 (1982) #50442y.
Bartelt, Diana C., et al., Archives of Biochemistry and Biophysics, vol. 179, (1977) pp. 189-199.
Eddeland, Allan, et al., Hoppe-Seyler's Z. Physiol, Chem., vol. 359, (Jun. 1978), pp. 671-675.
Kitahara, Takeshi, et al., Clinica Chimica Acta, vol. 103 (1980), pp. 135-143.
Huhtala Marja-Liisa
Stenman Ulf-Hakan
LandOfFree
Diagnostic method using oncofetal peptide as a tumor marker does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic method using oncofetal peptide as a tumor marker, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic method using oncofetal peptide as a tumor marker will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2174997